3D Medicines

company

About

3D Medicines mission is to improve people’s health through cancer personalized diagnostics and treatment.

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$140M
Industries
Biopharma,Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2010
Number Of Employee
501 - 1000
Operating Status
Active
Stock Symbol
hkg:1244
Legal Name
3D Medicines Corporation

3D Medicines, we use individual’s genetic information to prevent, diagnose, and treat cancer. We develop personalized medicines according to target population’s genetic background, to increase efficacy and safety.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
$140M ¥2.45B $251.10M
3D Medicines has raised a total of $140M ¥2.45B $251.10M in funding over 2 rounds. Their latest funding was raised on Dec 15, 2022 from a IPO round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 15, 2022 IPO $251.10M Detail
Nov 1, 2020 Series D 1 Detail
Oct 19, 2020 Private Equity(PE) ¥1.50B 11 CPE Detail
Oct 9, 2020 Series Unknown $140M 7 China Capital Management
EFung Capital
Detail
Jan 6, 2020 Series Unknown ¥280M 6 China Resources Pharmaceutical Industry Investment Fund Detail

Investments

Number of Investments
Number of Lead Investments
2
0
3D Medicines has made 2 investments. Their most recent investment was on Dec 16, 2015, when Motion AI raised $700K.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 16, 2015 Motion AI
Seed $700K Artificial Intelligence
Apr 1, 2011 Moon Active
Pre-seed Gaming

Employee Profiles

Number of Employee Profiles
5
3D Medicines has 5 current employee profiles, including Executive John Gong
Executive
Executive
Executive
Executive
Executive